Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001596783-24-000109
Filing Date
2024-11-01
Accepted
2024-11-01 17:17:29
Documents
1
Period of Report
2024-10-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1730495843.html 4  
1 FORM 4 wk-form4_1730495843.xml 4 3717
  Complete submission text file 0001596783-24-000109.txt   5246
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Issuer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALBIREO PHARMA, INC. 10 POST OFFICE SQUARE, SUITE 502 SOUTH BOSTON MA 02109
Business Address
Okey Stephanie (Reporting) CIK: 0001742616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36587 | Film No.: 241420031